Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 7 studies | 25% ± 8% | |
fibroblast | 6 studies | 29% ± 8% | |
connective tissue cell | 3 studies | 19% ± 4% | |
GABAergic neuron | 3 studies | 23% ± 6% | |
glutamatergic neuron | 3 studies | 27% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 2450.99 | 242 / 245 | 100% | 16.62 | 500 / 502 |
lung | 97% | 1176.70 | 561 / 578 | 93% | 10.63 | 1078 / 1155 |
thymus | 93% | 744.11 | 606 / 653 | 92% | 5.72 | 557 / 605 |
uterus | 99% | 4736.32 | 168 / 170 | 85% | 10.32 | 390 / 459 |
ovary | 100% | 2034.71 | 180 / 180 | 84% | 6.71 | 360 / 430 |
adrenal gland | 97% | 1123.75 | 250 / 258 | 84% | 4.84 | 193 / 230 |
bladder | 100% | 5123.43 | 21 / 21 | 77% | 6.96 | 389 / 504 |
esophagus | 81% | 2532.88 | 1171 / 1445 | 90% | 9.77 | 165 / 183 |
intestine | 84% | 4442.19 | 816 / 966 | 77% | 6.66 | 405 / 527 |
liver | 60% | 355.75 | 135 / 226 | 88% | 7.00 | 358 / 406 |
brain | 50% | 283.48 | 1316 / 2642 | 94% | 4.42 | 664 / 705 |
stomach | 62% | 1605.32 | 224 / 359 | 80% | 8.73 | 229 / 286 |
breast | 46% | 283.11 | 210 / 459 | 83% | 5.19 | 928 / 1118 |
kidney | 46% | 312.79 | 41 / 89 | 63% | 3.12 | 570 / 901 |
blood vessel | 100% | 3087.91 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.25 | 1 / 1 |
muscle | 99% | 1373.95 | 797 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 8.87 | 28 / 29 |
skin | 41% | 1206.99 | 742 / 1809 | 54% | 3.09 | 256 / 472 |
heart | 91% | 1345.67 | 781 / 861 | 0% | 0 | 0 / 0 |
adipose | 88% | 792.52 | 1061 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 4% | 21.99 | 14 / 328 | 81% | 5.09 | 144 / 178 |
tonsil | 0% | 0 | 0 / 0 | 73% | 4.24 | 33 / 45 |
eye | 0% | 0 | 0 / 0 | 45% | 3.48 | 36 / 80 |
spleen | 23% | 115.12 | 56 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 412.46 | 179 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901800 | Biological process | positive regulation of proteasomal protein catabolic process |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0006457 | Biological process | protein folding |
GO_0050821 | Biological process | protein stabilization |
GO_0010954 | Biological process | positive regulation of protein processing |
GO_1904667 | Biological process | negative regulation of ubiquitin protein ligase activity |
GO_0019538 | Biological process | protein metabolic process |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0005874 | Cellular component | microtubule |
GO_0030425 | Cellular component | dendrite |
GO_0101031 | Cellular component | protein folding chaperone complex |
GO_0005829 | Cellular component | cytosol |
GO_0030424 | Cellular component | axon |
GO_1901588 | Cellular component | dendritic microtubule |
GO_0000774 | Molecular function | adenyl-nucleotide exchange factor activity |
GO_0031072 | Molecular function | heat shock protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0048156 | Molecular function | tau protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | BAG2 |
Protein name | BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2) |
Synonyms | |
Description | FUNCTION: Co-chaperone for HSP70 and HSC70 chaperone proteins. Acts as a nucleotide-exchange factor (NEF) promoting the release of ADP from the HSP70 and HSC70 proteins thereby triggering client/substrate protein release . . |
Accessions | ENST00000370693.5 [O95816-1] O95816 |